Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
Fenil Shah, Derek P. Logsdon, Richard A. Messmann, et al.
npj Precision Oncology (2017) Vol. 1, Iss. 1
Open Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 423
8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification
Ja Young Hahm, Jongyeun Park, Eun-Sook Jang, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1626-1642
Open Access | Times Cited: 141
Organelle‐Specific Photoactivation of DNA Nanosensors for Precise Profiling of Subcellular Enzymatic Activity
Yulei Shao, Jian Zhao, Jinying Yuan, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 16, pp. 8923-8931
Closed Access | Times Cited: 134
Spatially resolved in vivo imaging of inflammation-associated mRNA via enzymatic fluorescence amplification in a molecular beacon
Chuangui Sheng, Jian Zhao, Zhenghan Di, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 9, pp. 1074-1084
Closed Access | Times Cited: 90
Ref-1 is overexpressed in neovascular eye disease and targetable with a novel inhibitor
Anbukkarasi Muniyandi, Gabriella D. Hartman, Kamakshi Sishtla, et al.
Angiogenesis (2025) Vol. 28, Iss. 1
Closed Access | Times Cited: 2
Not breathing is not an option: How to deal with oxidative DNA damage
Enni Markkanen
DNA repair (2017) Vol. 59, pp. 82-105
Open Access | Times Cited: 170
The multifunctional APE1 DNA repair–redox signaling protein as a drug target in human disease
Rachel A. Caston, Silpa Gampala, Lee Armstrong, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 1, pp. 218-228
Open Access | Times Cited: 90
Graphene Quantum Dot-Based Nanocomposites for Diagnosing Cancer Biomarker APE1 in Living Cells
Hao Zhang, Sai Ba, Zhaoqi Yang, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 12, pp. 13634-13643
Closed Access | Times Cited: 76
DNA Logic Circuits for Cancer Theranostics
Jing Chen, Shengnan Fu, Chunyi Zhang, et al.
Small (2022) Vol. 18, Iss. 20
Closed Access | Times Cited: 60
APE1/Ref-1 Role in Inflammation and Immune Response
Thais Teixeira Oliveira, Leonam Gomes Coutinho, Laysa Ohana Alves de Oliveira, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Development of a DNAzyme Walker for the Detection of APE1 in Living Cancer Cells
Jeffrey Tao, Hongquan Zhang, Michael Weinfeld, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 40, pp. 14990-14997
Open Access | Times Cited: 29
Revisiting Two Decades of Research Focused on Targeting APE1 for Cancer Therapy: The Pros and Cons
Matilde Clarissa Malfatti, Alessia Bellina, Giulia Antoniali, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1895-1895
Open Access | Times Cited: 23
Explainable AI-driven prediction of APE1 inhibitors: enhancing cancer therapy with machine learning models and feature importance analysis
Aga Basit Iqbal, Tariq Masoodi, Ajaz A. Bhat, et al.
Molecular Diversity (2025)
Closed Access | Times Cited: 1
Revascularization and limb salvage following critical limb ischemia by nanoceria-induced Ref-1/APE1-dependent angiogenesis
In‐Su Park, Chinmaya Mahapatra, Ji Sun Park, et al.
Biomaterials (2020) Vol. 242, pp. 119919-119919
Open Access | Times Cited: 68
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
Ying Zhang, Xuemei Xie, Pourya Naderi Yeganeh, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 9
Open Access | Times Cited: 54
Towards a comprehensive view of 8-oxo-7,8-dihydro-2’-deoxyguanosine: Highlighting the intertwined roles of DNA damage and epigenetics in genomic instability
Francesca Gorini, Giovanni Scala, Marcus S. Cooke, et al.
DNA repair (2020) Vol. 97, pp. 103027-103027
Open Access | Times Cited: 51
Cephalomannine inhibits hypoxia-induced cellular function via the suppression of APEX1/HIF-1α interaction in lung cancer
Asmat Ullah, Sze Wei Leong, Jingjing Wang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 50
Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT
Qing Li, Zhi-Wei Zhou, Wei Duan, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 50
Endogenous Enzyme-Powered DNA Nanomotor Operating in Living Cells for microRNA Imaging
Tong Li, Mengxu Sun, Qianying Zhou, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 40, pp. 15025-15032
Closed Access | Times Cited: 19
Stimuli‐Responsive DNA Circuits for High‐Performance Bioimaging Application
Qiong Wu, Mengqing Xu, Jinhua Shang, et al.
Advanced Sensor Research (2023) Vol. 2, Iss. 9
Open Access | Times Cited: 17
Functions of the major abasic endonuclease (APE1) in cell viability and genotoxin resistance
Daniel R. McNeill, Amy M. Whitaker, Wesley J. Stark, et al.
Mutagenesis (2019) Vol. 35, Iss. 1, pp. 27-38
Open Access | Times Cited: 53
Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target
Silpa Gampala, Fenil Shah, Xiaoyu Lu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 34
Enzymatically Controlled Nanoflares for Specific Molecular Recognition and Biosensing
Ya Zhao, Jian Zhao, Jingfang Zhang, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 25, pp. 8883-8889
Closed Access | Times Cited: 27
Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease
Anbukkarasi Muniyandi, Gabriella D. Hartman, Yang Song, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 386, Iss. 1, pp. 15-25
Open Access | Times Cited: 14
Unveiling Novel ERCC1–XPF Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental Design
Rita Manguinhas, Patrícia Serra, Rita B. Soares, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1246-1246
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top